Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 25
-1
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do zoonotic pathogens exist in Fijian bats and if so what are the risks of exposure to humans?

    Interactions between humans and bats can be both beneficial and detrimental. Habitat loss worldwide has increased...

    Dogs, Cats, and Scats: Saving Jaguars, One Poop at a Time

    The goal of our project is to improve connectivity of jaguar habitat in southern Mexico, an area of highly threatened...

    Backer Badge Funded